Genesis HealthCare Announces Resident and Staff COVID-19 Vaccine Acceptance Rates

Rhea-AI Summary

Genesis HealthCare announced that 84% of its skilled nursing residents and 61% of staff have received their first dose of the COVID-19 vaccine as of January 29, 2021. These rates surpass the national averages reported by the CDC. Genesis facilities began vaccinations on December 17, 2020, and aim to continue increasing acceptance rates through educational initiatives. The company is collaborating with Brown University to monitor vaccine safety among residents. Genesis operates over 325 skilled nursing facilities nationwide.

Positive

• 84% of skilled nursing residents vaccinated.
• 61% of staff vaccinated, exceeding national average.
• Successful vaccination program initiated on December 17, 2020.
• Collaboration with Brown University to monitor vaccine safety.

Negative

• None.

To date, 84% of skilled nursing residents and 61% of skilled nursing staff have been vaccinated; Staff acceptance rates far exceed national average as reported by CDC

KENNETT SQUARE, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Genesis HealthCare, (“Genesis” or “Company”) (NYSE: GEN), one of the largest post-acute care providers in the United States, announced today that 84% of its skilled nursing residents and 61% of skilled nursing staff members have been vaccinated, each receiving their first dose of the COVID-19 vaccine, through January 29, 2021. Staff vaccine acceptance rates far exceed the national average, and resident acceptance rates at Genesis skilled nursing centers were also above the national average, based on vaccine administration data in an analysis published by the Centers for Disease Control and Prevention (CDC).

On February 1, 2021, the CDC announced that “among 11,460 SNFs with at least one vaccination clinic conducted during the first month of the CDC Pharmacy Partnership for Long-Term Care Program, a median of 77.8% of residents and 37.5% of staff members received ≥1 vaccine dose through the program.”

“I am so extraordinarily proud of the progress our centers have made vaccinating both residents and staff,” states Dr. Richard Feifer, Chief Medical Officer of Genesis. “Our leadership team, clinicians, physicians and advanced practice providers have been working around the clock to educate patients, residents, staff and families about the importance of being vaccinated, and to answer every point of hesitancy or concern with a combination of compassion and factual information. These acceptance rates are a testament to the hard work and dedication our leadership and center staff have shown throughout this entire pandemic. We are not done yet, and continue our work to increase vaccination rates even higher.”

As of January 21, 2021, 100% of Genesis skilled nursing facilities received dose one of the vaccine, primarily utilizing CVS Health, our primary partner through the Pharmacy Partnership for Long Term Care program. Genesis facilities were among the first to begin vaccinations in nursing homes, beginning on December 17, 2020. After the first clinic, the pharmacists return three to four weeks later to administer the second booster shots for those who received the vaccine in round one, and will also vaccinate anyone not included in round one. The pharmacists will then return for a third time, three to four weeks after round two, to administer the final booster shots. Genesis skilled nursing facilities are approximately 67% through their second clinics.

Genesis continues its robust communications and engagement initiatives to build trust among patients, residents, families and staff. Genesis has conducted ‘Ask the Doc’ sessions, social media campaigns, educational outreach, and a variety of other engagement tactics to promote vaccination. Multiple second clinics are ongoing every day and Genesis facilities are striving to get as many people vaccinated as quickly as possible at each clinic. The Company expects acceptance rates to continue to climb.

All drugs or vaccines have some potential side effects, and it is important to monitor for such issues even after a drug or vaccine is approved. Thus far, there have been minimal reported side effects after patients, residents and staff have received the vaccine. As the largest nursing home operator, Genesis is participating in a newly developed safety monitoring program with Brown University School of Public Health researchers, to monitor for any potential adverse health impacts after nursing home residents in our centers receive COVID-19 vaccinations. This work is part of a CDC effort to carefully monitor vaccine safety, particularly focused on frail elderly residents who were not included in vaccine trials.

About Genesis HealthCare
Genesis HealthCare is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's largest post-acute care companies, providing services to more than 325 skilled nursing facilities and assisted/senior living communities in 24 states nationwide. Genesis subsidiaries also supply rehabilitation therapy to approximately 1,100 healthcare providers in 44 states, the District of Columbia and China. References made in this release to "Genesis," "the Company," "we," "us" and "our" refer to Genesis Healthcare, Inc. and each of its wholly-owned companies. Visit our website at www.genesishcc.com.

Media Contact:	Lori Mayer
	610-283-4995

FAQ

What percentage of Genesis HealthCare staff have been vaccinated?

As of January 29, 2021, 61% of Genesis HealthCare staff have been vaccinated.

How does Genesis HealthCare's vaccination rate compare to the national average?

Genesis HealthCare's vaccination rates exceed the national averages reported by the CDC.

When did Genesis HealthCare start its vaccination program?

Genesis HealthCare began its vaccination program on December 17, 2020.

What is the vaccination rate among skilled nursing residents at Genesis HealthCare?

84% of skilled nursing residents at Genesis HealthCare have received their first dose of the COVID-19 vaccine.

Is Genesis HealthCare monitoring vaccine safety?

Yes, Genesis is participating in a safety monitoring program with Brown University to observe any potential adverse health impacts.